Oklo Inc ( (OKLO) ) has fallen by -7.81%. Read on to learn why.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Oklo Inc shares fell 7.81% over the past week, even as the advanced nuclear start-up continued to post major technical milestones and attract high‑profile investors. The stock, which has already surged more than 280% year-to-date, saw bouts of profit-taking and volatility after recent sharp moves, with mixed analyst sentiment and broader market jitters adding pressure. Despite the pullback, trading activity remained heavy, reflecting strong ongoing interest in the name.
On the fundamental side, Oklo reported progress on its plutonium‑fueled fast reactor program, conducting a multi-day critical test campaign with Los Alamos National Laboratory under the U.S. Department of Energy’s Reactor Pilot Program. The company also recently secured DOE approval for safety documentation tied to its Aurora Fuel Fabrication Facility, both seen as key steps toward de‑risking its technology, qualifying surplus plutonium as commercial reactor fuel, and accelerating its path to eventual licensing and commercialization. These developments underpin a long-term strategy that goes beyond power generation to include HALEU fuel fabrication and radioisotope sales, with bullish revenue projections extending into the 2030s.
Wall Street remains broadly constructive despite near‑term turbulence. H.C. Wainwright reiterated a Buy rating on Oklo Inc with a $90 price target, citing its “revolutionary” reactor technology and ambitious growth plan, while Seaport Global recently upgraded the stock to Buy with a $150 target. At the same time, Craig-Hallum and UBS have stuck to Hold ratings, reflecting execution and valuation risks after the stock’s big run. Adding to the cross‑currents, Cathie Wood’s ARK Investment stepped in to buy over 107,000 Oklo shares, signaling continued institutional conviction even as the stock digests recent gains.

